Medical Device News Magazine

Ultraviolet Germicidal Irradiation Global Market Report 2022-2026

Efficiency and Improved ROI Make UV-C Disinfection Technology an Ideal Option for Hospitality Industry

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The “Ultraviolet Germicidal Irradiation (UVGI) – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Amid the COVID-19 crisis, the global market for Ultraviolet Germicidal Irradiation estimated at US$454.4 Million in the year 2022, is projected to reach a revised size of US$682.9 Million by 2026, growing at a CAGR of 12% over the analysis period. Air Disinfectant, one of the segments analyzed in the report, is projected to grow at a 12.3% CAGR to reach US$646.1 Million by the end of the analysis period.

The COVID-19 crisis is fostering the ultraviolet (UV) disinfection equipment market by creating a pressing need to effectively deal with the deadly virus. UV disinfection represents a chemical-free process that exposes pathogens in a gaseous or liquid medium or on surfaces to UV irradiation for deactivating the DNA to hinder reproduction of the pathogen.

Several studies have indicated that the use of a specific wavelength of UV light can kill over 99.9% of COVID-19 viruses present on surfaces and in airborne droplets. In addition, UVC germicidal irradiation offers effective physical disinfection as well as holds optimal germicidal effect and doesn`t leave any residues.

These benefits have resulted in strong demand and adoption of UV disinfection equipment across healthcare settings, offices and other work spaces. The COVID-19 outbreak provided a significant impetus to global shipment of UV disinfection equipment, a trend that is unlikely to abate soon.

 After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Surface Disinfectant segment is readjusted to a revised 10.3% CAGR for the next 7-year period. This segment currently accounts for a 14.2% share of the global Ultraviolet Germicidal Irradiation market.

The U.S. Market is Estimated at $149.1 Million in 2022, While China is Forecast to Reach $73.7 Million by 2026

The Ultraviolet Germicidal Irradiation market in the U.S. is estimated at US$149.1 Million in the year 2022. The country currently accounts for a 33.51% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$73.7 Million in the year 2026 trailing a CAGR of 15% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 10.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.8% CAGR while Rest of European market (as defined in the study) will reach US$81.2 Million by the close of the analysis period.

Key Players

  • American Ultraviolet
  • Atlantic Ultraviolet Corporation
  • Ensavior
  • Excelitas Technologies Corp.
  • General Electric Company
  • Halma plc
  • Signify Holding
  • UltraViolet Devices, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Upper-Room UVGI: A Useful Ventilation Solution to Combat COVID-19
  • Rising Incidence of Hospital Acquired Infections Propel Demand
  • Focus on HAI Prevention Practices Drives Demand
  • High Touch Surfaces: The Major Causative Factor in HAIs
  • Renewed Threat of Infectious Diseases to Drive Adoption
  • Ultraviolet Germicidal Irradiation for Commercial Settings
  • Mobile UV Systems and Handheld UV Sanitizers Come to the Fore
  • Trend towards Preventive Healthcare Benefits Disinfectants Market
  • Market Witnesses Influx of New UV Disinfection Robots
  • The Way Forward
  • Mitigating COVID-19 Transmission Risk in Hospitals Gets Interesting at UV Disinfection Robot Levels
  • Lucrative Prospects in the Airports Vertical
  • Efficiency and Improved ROI Make UV-C Disinfection Technology an Ideal Option for Hospitality Industry
  • Benefits of UV-C Disinfection for Hospitality and Lodging Industry
  • Restaurants Bet on UV Germicidal Irradiation for Safer Environments
  • Robust Opportunities in Cinema Halls & Shopping Malls
  • Stringent Regulations Regarding Food Safety to Augment Deployment of UV Disinfection
  • Food Sterilization Applications for UVC Germicidal Lamps
  • Cold Storage and Refrigerated Spaces for Fruits and Vegetables Augment Demand

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”